Expand Manufacturing Capacity

• Increased prophylaxis

• Aging population and increased weight

• Increased conversion from pdFVIII(due to perceived viral safety concerns)

• Increased surgeries / filling supply channels

• Improving access to quality care in new markets

Recombinant Market Growth ᡌ%

Increased Global Recombinant FVIII Demand

Previous slide

Next slide

Back to first slide

View graphic version